Synaptogenix Inc (SNPX)

[Battle Ready]

I know there have to be rigorous controls in place, but is there a chance that the real drug and placebo got mixed up in part of the trial??

Separately, the sell off is an absurd overreaction to the deeply disappointing news. As I posted before the trial results, IMHO, the company should be worth $50-100 million based upon cash, patents and licenses... The bad outcome is a big setback but it just means they have to figure things out. The fact remains that Bryostatin has done some remarkable things for many people and still has potential across multiple CNS diseases... To a big pharma company, $50-100 million is a rounding error and they can commit the resources to properly advancing the drug forward...